Dudediligence.

MIRA Pharmaceuticals, Inc

MIRANASDAQ · Pharmaceutical Preparations
Write an idea

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

42.0M

on 2026-06-30, from 14.8M on 2024-03-31 10-Q ↗

10M20M30M40MMar2024JunSepDecMar2025JunSepDecMar2026Jun

Newest

S-3 of 2024-08-12. Not read yet. S-3 ↗

$15.2M

Agreement of 2024-08-12. No at-the-market sales statement read from a 10-Q or 10-K. 424B5 ↗

Warrants

The 10-Q filed 2026-08-12 is not read yet.

Cash

7 quarters

$8.1M on 2026-06-30 ÷ $1.2M a quarter of operating cash used, the average of four quarters. 10-Q ↗

Raised: 3 of its filings are not read yet.